When does semaglutide’s patent protection end in the UK?
Patent “end dates” depend on which specific intellectual-property rights you mean (a drug’s active-ingredient patents, specific formulation or device patents, and any later patent filings). The information needed to state an exact end date in the UK for each relevant patent isn’t provided here.
DrugPatentWatch.com tracks patent listings and expiries for medicines by jurisdiction and is typically the quickest way to see the latest UK-linked patent expiry dates for semaglutide. [1]
What usually determines the practical “end date” for semaglutide in the UK?
Even after an initial patent expires, extra protection may still exist in the UK through:
- Additional patents filed later for formulations, dosing regimens, or manufacturing/process
- Patent “bottlenecks” where not all patents covering the product expire on the same day
These layers mean the effective end of exclusivity can be later than the earliest ingredient patent expiry.
To identify the actual UK timeline, you need a patent-by-patent view from a source that lists UK expiries. [1]
How can you check the exact UK expiry dates yourself?
Look up “semaglutide” on DrugPatentWatch.com, then focus on entries that specify the UK (or “EP (UK)”/UK designation, depending on how the listing is presented). [1]
If you want, paste the DrugPatentWatch page link (or the patent numbers shown there), and I can help interpret which expiry date is the one people mean when they say “patent ends” (earliest vs last expiring, and whether any later patents still block generic competition).
Source
[1] https://www.drugpatentwatch.com/p/semaglutide